CRISPR Therapeutics


CRISPR Therapeutics Stock Quote
$199.88 -$10.16 -4.8%
Price as of January 15, 2021, 9:00 p.m. EST View Interactive CRSP Charts

CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.

Interactive Chart

News & Analysis: CRISPR Therapeutics

The Fool has written over 200 articles on CRISPR Therapeutics.


Market Moves


Is CRISPR Therapeutics Heading for $170?

Analysts have been raising their price targets on the stock based on news about a treatment the biotech is developing in partnership with Vertex Pharmaceuticals.